CRPG.F Stock Overview
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
China Resources Pharmaceutical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.56 |
| 52 Week High | HK$0.56 |
| 52 Week Low | HK$0.56 |
| Beta | 0.38 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRPG.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -0.7% |
| 1Y | n/a | 11.6% | 22.3% |
Return vs Industry: Insufficient data to determine how CRPG.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how CRPG.F performed against the US Market.
Price Volatility
| CRPG.F volatility | |
|---|---|
| CRPG.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CRPG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CRPG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 71,000 | Xiaosong Bai | www.crpharm.com |
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.
China Resources Pharmaceutical Group Limited Fundamentals Summary
| CRPG.F fundamental statistics | |
|---|---|
| Market cap | US$3.70b |
| Earnings (TTM) | US$531.89m |
| Revenue (TTM) | US$34.18b |
7.0x
P/E Ratio0.1x
P/S RatioIs CRPG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRPG.F income statement (TTM) | |
|---|---|
| Revenue | HK$267.33b |
| Cost of Revenue | HK$225.69b |
| Gross Profit | HK$41.64b |
| Other Expenses | HK$37.48b |
| Earnings | HK$4.16b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.66 |
| Gross Margin | 15.58% |
| Net Profit Margin | 1.56% |
| Debt/Equity Ratio | 81.3% |
How did CRPG.F perform over the long term?
See historical performance and comparison